Finance

Beta
Lists
LTRN:NASDAQ
Lantern Pharma Inc
$3.88
+1.84%
(+0.070) 1D
$3.90
+0.52% (+0.020)
Pre-market
Closed: Jun 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LTRN...
Open
$3.78
High
$4.12
Low
$3.75
Mkt. cap
49.50M
Avg. vol.
297.64K
Volume
21.37K
52-wk high
$5.74
52-wk low
$1.11
EPS
-$1.45
Beta
2.33
Shares outstanding
11.30M
No. of employees
16
Open
$3.78
High
$4.12
Low
$3.75
Mkt. cap
49.50M
Avg. vol.
297.64K
Volume
21.37K
52-wk high
$5.74
52-wk low
$1.11
EPS
-$1.45
Beta
2.33
Shares outstanding
11.30M
No. of employees
16
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to LTRN in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for LTRN in the last 3 months.
Highest
Current $3.88
$25.00 (+544.33%)
Average
$25.00 (+544.33%)
Lowest
$25.00 (+544.33%)
News stories
From sources across the web
About Lantern Pharma Inc
CEO-
Employees16
Founded2013
HeadquartersDallas, Texas, United States
SectorBiotechnology
Websitelanternpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.07M
2.44M
2.74M
1.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.58M
1.91M
1.46M
1.68M
Operating expense
4.65M
4.35M
4.20M
3.41M
Total operating expenses
4.65M
4.35M
4.20M
3.41M
Operating income
-4.65M
-4.35M
-4.20M
-3.41M
Other non operating income
206.14K
71.46K
63.47K
33.92K
EBT including unusual items
-4.33M
-4.18M
-4.07M
-3.33M
EBT excluding unusual items
-4.33M
-4.18M
-4.07M
-3.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.33M
-4.18M
-4.07M
-3.33M
Net profit margin
-
-
-
-
Earnings per share
-0.40
-0.39
-0.36
-0.30
Interest and investment income
114.74K
100.92K
72.48K
42.16K
Interest expense
-
-
-
-
Net interest expenses
114.74K
100.92K
72.48K
42.16K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.65M
-4.35M
-4.20M
-3.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer